Shop
Applications
Technology
Company

Lectenz Bio at 2022 Common Fund GlycoScience Program

HomeAll postsLectenz® Bio NewsLectenz Bio at 2022 Common Fund GlycoScience...

by dschulz May 4, 2022 in Lectenz® Bio News 0 0

Lectenz Bio was excited to have CEO Lori Yang and VP of R&D Sean Wu present at the Common Fund GlycoScience Program!

GlycoSense Paper Published in Scientific Reports

Dr. Sean Wu, Vice President of R&D

Search

Twitter

Lectenz Bio ·
@lectenz_bio

Our VP of R&D Dr. Sean Wu is attending this great meeting! https://t.co/UyN3nWyhqD

View on Twitter

Lance Wells@DocGatorDawg1
Blue Square 🟦 Crowd at the ASBMB Meeting at CCRC, UGA https://t.co/iaUv1OpKzU

Lectenz Bio ·
@lectenz_bio

https://t.co/bVwZQzSOJg

View on Twitter

Lectenz Bio ·
@lectenz_bio

Our Operations Manager, Christian Gerner-Smidt, gave an exciting presentation on our Lectenz reagents at the 2022 Mid-South Glycoscience Meeting! https://t.co/n8rPthBQcQ

View on Twitter

Follow @lectenz_bio

Instagram

Instagram did not return a 200.

Products

Thermophilic Fucosidase $125.00
5X SiaFind™ Binding Buffer 3 $50.00
5X SiaFind™ Regeneration Buffer 1 $50.00
SiaRich™ Alpha 2,3-Specific Column $450.00
5X SiaFind™ Binding Buffer 2 $50.00

About Us

Lectenz® Bio is commercializing enabling technologies for applications in glycoscience and delivering tools that advance research and clinical applications.

FOLLOW US

Email List

Subscribe to our mailing list:

By providing us with your contact details, you accept our Privacy Policy

Leave this field empty if you're human:

Contact Info

  111 Riverbend Road
      Athens, GA 30602
      U.S.A.
+1 (706) 549-4484
info@lectenz.com
      Contact Us

QUICKLINKS
      Terms and Conditions
      Privacy Policy

Website By: JH Media Group: Healthcare & Diagnostic Imaging Website Design & Lead Generation

New Customer Form

Lectenz Bio at 2022 Common Fund GlycoScience Program

Related Posts

GlycoSense Paper Published in Scientific Reports

Dr. Sean Wu, Vice President of R&D